Keywords: immune, response, ph, ii, data, corp, released

Immune Response's Ph II Data

Article | 20 January 1997

Print This

The Immune Response Corp has released data from Phase II clinical trialswith its immune-based therapies for rheumatoid arthritis and psoriasis.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in